About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

DAIKEN MEDICAL CO.,LTD, First Half Ordinary Profit Unexpectedly Revised Upward by 11%

Thu Oct 31, 2024 4:00 pm JST Earnings

7775 DAIKEN MEDICAL CO.,LTD 【J-GAAP】

Earnings Report

DAIKEN MEDICAL CO.,LTD <7775> [TSE-S] announced its financial results after the market closed on October 31st (16:00). The ordinary profit (non-consolidated) for the cumulative second quarter of the fiscal year ending March 2025 (April to September) increased by 11.5% from the same period last year, reaching 836 million yen, resulting in an increase in profits compared to the previous forecast of a 6.7% decrease.

The progress rate against the 1.5 billion yen full-year plan was 55.7%, also surpassing the five-year average of 51.4%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the ordinary profit for the October to March period (second half) is expected to decrease by 5.1% from the same period last year to 664 million yen.

In the most recent three-month period, from July to September (2Q), the ordinary profit grew by 7.1% from the same period last year, reaching 438 million yen. The operating profit margin rose from 16.5% in the same period last year to 17.4%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2022 4,454 605 605 429 14.9 57.5 Oct 31, 2022 J-GAAP
Apr - Sep, 2023 4,824 745 750 537 18.7 51.7 Oct 31, 2023 J-GAAP
Apr - Sep, 2024 4,914 836 836 608 21.2 55.7 Oct 31, 2024 J-GAAP
YoY +1.9% +12.2% +11.5% +13.2% +13.2%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 Guidance 4,950 700 700 480 16.7 9 May 15, 2024 J-GAAP
Apr - Sep, 2024 Results 4,914 836 836 608 21.2 9 Oct 31, 2024 J-GAAP
Revision Rate -0.7% +19.4% +19.4% +26.7% +26.8%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2023 4,926 697 700 451 15.7 12 May 15, 2024 J-GAAP
Oct - Mar, 2024 Guidance 5,186 664 664 422 14.7 13 Oct 31, 2024 J-GAAP
YoY +5.3% -4.7% -5.1% -6.4% -6.5%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 9,137 1,054 1,053 712 24.8 20 May 15, 2023 J-GAAP
Mar, 2024 9,750 1,442 1,450 988 34.4 21 May 15, 2024 J-GAAP
Mar, 2025 Guidance 10,100 1,500 1,500 1,030 35.9 22 May 15, 2024 J-GAAP
YoY +3.6% +4.0% +3.4% +4.3% +4.2%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2023 2,463 406 409 293 10.2 16.5 Oct 31, 2023 J-GAAP
Oct - Dec, 2023 2,582 492 492 351 12.2 19.1 Jan 31, 2024 J-GAAP
Jan - Mar, 2024 2,344 205 208 100 3.5 8.7 May 15, 2024 J-GAAP
Apr - Jun, 2024 2,395 397 398 289 10.1 16.6 Jul 31, 2024 J-GAAP
Jul - Sep, 2024 2,519 439 438 319 11.1 17.4 Oct 31, 2024 J-GAAP
YoY +2.3% +8.1% +7.1% +8.9% +8.9%

Related Articles